Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.470
-0.025-0.45%
Volume:96.40M
Turnover:530.50M
Market Cap:102.20B
PE:35.97
High:5.680
Open:5.525
Low:5.445
Close:5.495
52wk High:8.442
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:1.42
T/O Rate:0.52%
Dividend:0.12
Dividend Rate:2.25%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.68
PE(LYR):35.97
PS:2.59

Loading ...

Daiwa Reaffirms Buy Rating on SBP Group After Management Reiterates Double-Digit Revenue Growth Target for the Year

Deep News
·
Yesterday

Daiwa Highlights SBP Group's Reaffirmed Double-Digit Revenue Growth Target for This Year, Retains "Buy" Rating

Stock News
·
Sep 18

Movement Alert|SBP GROUP Rises 3.18% in Regular Trading, Dual NDA Acceptances and CT Tianqing Stake Increase Completion Fuel Gains

Market Focus
·
Sep 18

Hong Kong Stocks in Focus: SBP Group Jumps Nearly 3% on Double New Drug Approval Submissions

Stock News
·
Sep 16

Sino Biopharmaceutical Says China's CDE Accepts NDA for Tqh2722 Injection

Reuters
·
Sep 16

Hong Kong Market Open: Hang Seng Index Rises 0.50% as Optics Stocks Rally, CATL Slides Over 2%

Stock News
·
Sep 16

Chinese Regulator Accepts NDA for Sino Biopharm's Breast Cancer Drug

MT Newswires Live
·
Sep 16

Sino Biopharm (SBP Group) Receives CDE Acceptance of NDA for IL-4Rα Monoclonal Antibody TQH2722 Targeting Moderate-to-Severe Atopic Dermatitis

Bulletin Express
·
Sep 16

China Biopharmaceuticals Advances Novel HER2-Targeting Bispecific ADC Toward Market Approval

Stock News
·
Sep 16

Sino Biopharmaceutical - China Cde Accepts New Drug Application for Tqb2102 Injection

THOMSON REUTERS
·
Sep 16

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Dow Jones
·
Sep 15

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Sino Biopharmaceutical Climbs on Plan to Raise Stake in Core Unit

Reuters
·
Sep 14

Goldman Sachs Lifts SBP Group Target Price to HK$9.07, Reaffirms Buy Rating

Stock News
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

Movement Alert|SBP GROUP Rises 3.14% in Regular Trading, Plans RMB 4.48 Billion Acquisition to Raise CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Movement Alert|SBP GROUP Rises 3.43% at Open, Plans RMB 4.48 Billion Acquisition to Boost CT Tianqing Stake to 65%

Market Focus
·
Sep 14

Biopharma Giant's HK$4.48 Billion Stake Purchase Highlights Key Hong Kong Stock Market Announcements

Stock News
·
Sep 14

Crude Supply Shock Looms as Saudi Pipeline Outage Threatens 4% of Global Output

Stock News
·
Sep 14